AstraZeneca (LON:AZN) Share Price Passes Above 200-Day Moving Average - What's Next?

Key Points

• AstraZeneca shares crossed above the 200-day moving average, trading at £119.70 ($162.02) after reaching a high of £121.30 ($164.19).
• Analysts maintain a generally positive outlook, with several upgrades including a "buy" rating from Shore Capital with a target of £135 and from Berenberg Bank with a target of £142.
• Insider Aradhana Sarin sold 9,563 shares at an average price of £115.12, highlighting insider activity as part of the stock's performance analysis.

AstraZeneca PLC (LON:AZN - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of £109.31 ($148.27) and traded as high as £121.30 ($164.54). AstraZeneca shares last traded at £119.70 ($162.37), with a volume of 1,129,976 shares trading hands.

Analyst Ratings Changes

AZN has been the topic of several recent analyst reports. Shore Capital reaffirmed a "buy" rating and set a £135 target price on shares of AstraZeneca in a research report on Tuesday, July 29th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a £110 price objective on shares of AstraZeneca in a report on Wednesday, July 30th. Finally, Berenberg Bank reissued a "buy" rating and issued a £142 price objective on shares of AstraZeneca in a report on Monday, September 1st. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of £131.75.

AstraZeneca Stock Down 1.4%

The company has a quick ratio of 0.59, a current ratio of 0.93 and a debt-to-equity ratio of 73.83. The stock has a market cap of £182.84 billion, a PE ratio of 2,221.09, a P/E/G ratio of 0.86 and a beta of 0.17. The business has a 50 day moving average price of £112.75 and a 200 day moving average price of £109.39.

Insider Activity at AstraZeneca

In other news, insider Aradhana Sarin sold 9,563 shares of the company's stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of £115.12, for a total value of £1,100,892.56. 0.14% of the stock is owned by insiders.

AstraZeneca Company Profile

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.